Seres Therapeutics Inc

NASDAQ:MCRB

0.81

+0.04 (+4.77%)

7:54:02 PM EDT: $0.78 -0.03 (-3.17%)

Market Cap (Intraday)	143.85M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$25.83 Million
Adjusted EPS	-$0.07

See more estimates

10-Day MA	$0.83
50-Day MA	$0.93
200-Day MA	$0.97

See more pivots

Seres Therapeutics Inc Stock, NASDAQ:MCRB

200 Sidney Street, 4th floor, Cambridge, Massachusetts 02139

United States of America

Phone: +1.617.945.9626

Number of Employees: 233

http://www.serestherapeutics.com

Description

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.